---
title: "De Novo &amp; Breakthrough Pathways - Learning Path - MedTech Terms"
description: "Novel and expedited FDA pathways for devices with no predicate or that address unmet needs, plus Q-Submission and Pre-Submission mechanics."
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": [
          "Course",
          "LearningResource"
        ],
        "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course",
        "name": "De Novo & Breakthrough Pathways",
        "description": "Novel and expedited FDA pathways for devices with no predicate or that address unmet needs, plus Q-Submission and Pre-Submission mechanics.",
        "url": "https://medtechterms.com/paths/de-novo-and-breakthrough",
        "courseCode": "de-novo-and-breakthrough",
        "educationalLevel": "Professional",
        "learningResourceType": "Curriculum",
        "inLanguage": "en",
        "teaches": [
          "De Novo Classification Request",
          "Breakthrough Device Designation",
          "Pre-Submission Meeting",
          "Q-Submission (Pre-Submission)",
          "Intended Use",
          "Indications for Use",
          "Predicate Device",
          "Substantial Equivalence",
          "510(k) Premarket Notification",
          "Premarket Approval",
          "Combination Product"
        ],
        "about": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/de-novo#term",
            "name": "De Novo Classification Request",
            "alternateName": "De Novo",
            "url": "https://medtechterms.com/terms/de-novo"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/breakthrough-device#term",
            "name": "Breakthrough Device Designation",
            "alternateName": "BDD",
            "url": "https://medtechterms.com/terms/breakthrough-device"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/pre-submission#term",
            "name": "Pre-Submission Meeting",
            "alternateName": "Q-Sub",
            "url": "https://medtechterms.com/terms/pre-submission"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/q-sub#term",
            "name": "Q-Submission (Pre-Submission)",
            "alternateName": "Q-Sub / Pre-Sub",
            "url": "https://medtechterms.com/terms/q-sub"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/intended-use#term",
            "name": "Intended Use",
            "url": "https://medtechterms.com/terms/intended-use"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/indications-for-use#term",
            "name": "Indications for Use",
            "alternateName": "IFU (statement)",
            "url": "https://medtechterms.com/terms/indications-for-use"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/predicate-device#term",
            "name": "Predicate Device",
            "url": "https://medtechterms.com/terms/predicate-device"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/substantial-equivalence#term",
            "name": "Substantial Equivalence",
            "alternateName": "SE",
            "url": "https://medtechterms.com/terms/substantial-equivalence"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/510k#term",
            "name": "510(k) Premarket Notification",
            "alternateName": "510(k)",
            "url": "https://medtechterms.com/terms/510k"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/pma#term",
            "name": "Premarket Approval",
            "alternateName": "PMA",
            "url": "https://medtechterms.com/terms/pma"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/combination-product#term",
            "name": "Combination Product",
            "url": "https://medtechterms.com/terms/combination-product"
          }
        ],
        "audience": {
          "@type": "EducationalAudience",
          "educationalRole": "RA · Startup · Product"
        },
        "provider": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com",
          "sameAs": [
            "https://bluegoatcyber.com"
          ]
        },
        "offers": {
          "@type": "Offer",
          "price": "0",
          "priceCurrency": "USD",
          "category": "Free",
          "availability": "https://schema.org/InStock"
        },
        "hasCourseInstance": {
          "@type": "CourseInstance",
          "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#instance",
          "courseMode": "Online",
          "courseWorkload": "PT55M",
          "inLanguage": "en",
          "instructor": {
            "@type": "Person",
            "name": "Christian Espinosa",
            "jobTitle": "Founder, Blue Goat Cyber",
            "url": "https://medtechterms.com/authors/christian-espinosa"
          }
        },
        "hasPart": [
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/de-novo#lesson-de-novo-and-breakthrough",
            "name": "De Novo Classification Request",
            "url": "https://medtechterms.com/terms/de-novo",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The pathway for novel low- to moderate-risk devices with no predicate.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/de-novo#term",
              "name": "De Novo Classification Request",
              "alternateName": "De Novo",
              "url": "https://medtechterms.com/terms/de-novo"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/breakthrough-device#lesson-de-novo-and-breakthrough",
            "name": "Breakthrough Device Designation",
            "url": "https://medtechterms.com/terms/breakthrough-device",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "Designation that unlocks expedited FDA interaction, not a separate submission type.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/breakthrough-device#term",
              "name": "Breakthrough Device Designation",
              "alternateName": "BDD",
              "url": "https://medtechterms.com/terms/breakthrough-device"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/pre-submission#lesson-de-novo-and-breakthrough",
            "name": "Pre-Submission Meeting",
            "url": "https://medtechterms.com/terms/pre-submission",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The most valuable free tool FDA offers: written feedback before you file.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/pre-submission#term",
              "name": "Pre-Submission Meeting",
              "alternateName": "Q-Sub",
              "url": "https://medtechterms.com/terms/pre-submission"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/q-sub#lesson-de-novo-and-breakthrough",
            "name": "Q-Submission (Pre-Submission)",
            "url": "https://medtechterms.com/terms/q-sub",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The umbrella program that contains Pre-Sub, Study Risk Determination, and more.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/q-sub#term",
              "name": "Q-Submission (Pre-Submission)",
              "alternateName": "Q-Sub / Pre-Sub",
              "url": "https://medtechterms.com/terms/q-sub"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/intended-use#lesson-de-novo-and-breakthrough",
            "name": "Intended Use",
            "url": "https://medtechterms.com/terms/intended-use",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The single sentence that anchors your whole regulatory strategy.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/intended-use#term",
              "name": "Intended Use",
              "url": "https://medtechterms.com/terms/intended-use"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/indications-for-use#lesson-de-novo-and-breakthrough",
            "name": "Indications for Use",
            "url": "https://medtechterms.com/terms/indications-for-use",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The clinical situations your device is labeled for; drives evidence requirements.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/indications-for-use#term",
              "name": "Indications for Use",
              "alternateName": "IFU (statement)",
              "url": "https://medtechterms.com/terms/indications-for-use"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/predicate-device#lesson-de-novo-and-breakthrough",
            "name": "Predicate Device",
            "url": "https://medtechterms.com/terms/predicate-device",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "Why De Novo exists: what you file when no acceptable predicate is available.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/predicate-device#term",
              "name": "Predicate Device",
              "url": "https://medtechterms.com/terms/predicate-device"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/substantial-equivalence#lesson-de-novo-and-breakthrough",
            "name": "Substantial Equivalence",
            "url": "https://medtechterms.com/terms/substantial-equivalence",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "The 510(k) test you cannot meet, which is why you're reading this path.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/substantial-equivalence#term",
              "name": "Substantial Equivalence",
              "alternateName": "SE",
              "url": "https://medtechterms.com/terms/substantial-equivalence"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/510k#lesson-de-novo-and-breakthrough",
            "name": "510(k) Premarket Notification",
            "url": "https://medtechterms.com/terms/510k",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "Compare to see why De Novo is different in evidence and outcome.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/510k#term",
              "name": "510(k) Premarket Notification",
              "alternateName": "510(k)",
              "url": "https://medtechterms.com/terms/510k"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/pma#lesson-de-novo-and-breakthrough",
            "name": "Premarket Approval",
            "url": "https://medtechterms.com/terms/pma",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "Where you end up if FDA decides your device belongs in Class III instead.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/pma#term",
              "name": "Premarket Approval",
              "alternateName": "PMA",
              "url": "https://medtechterms.com/terms/pma"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          },
          {
            "@type": "LearningResource",
            "@id": "https://medtechterms.com/terms/combination-product#lesson-de-novo-and-breakthrough",
            "name": "Combination Product",
            "url": "https://medtechterms.com/terms/combination-product",
            "learningResourceType": "Lesson",
            "inLanguage": "en",
            "description": "Extra Center-assignment step for device + drug or device + biologic products.",
            "about": {
              "@type": "DefinedTerm",
              "@id": "https://medtechterms.com/terms/combination-product#term",
              "name": "Combination Product",
              "url": "https://medtechterms.com/terms/combination-product"
            },
            "isPartOf": {
              "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#course"
            }
          }
        ]
      },
      {
        "@type": "ItemList",
        "@id": "https://medtechterms.com/paths/de-novo-and-breakthrough#itemlist",
        "name": "De Novo & Breakthrough Pathways",
        "itemListOrder": "https://schema.org/ItemListOrderAscending",
        "numberOfItems": 11,
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "url": "https://medtechterms.com/terms/de-novo",
            "name": "De Novo Classification Request",
            "description": "The pathway for novel low- to moderate-risk devices with no predicate."
          },
          {
            "@type": "ListItem",
            "position": 2,
            "url": "https://medtechterms.com/terms/breakthrough-device",
            "name": "Breakthrough Device Designation",
            "description": "Designation that unlocks expedited FDA interaction, not a separate submission type."
          },
          {
            "@type": "ListItem",
            "position": 3,
            "url": "https://medtechterms.com/terms/pre-submission",
            "name": "Pre-Submission Meeting",
            "description": "The most valuable free tool FDA offers: written feedback before you file."
          },
          {
            "@type": "ListItem",
            "position": 4,
            "url": "https://medtechterms.com/terms/q-sub",
            "name": "Q-Submission (Pre-Submission)",
            "description": "The umbrella program that contains Pre-Sub, Study Risk Determination, and more."
          },
          {
            "@type": "ListItem",
            "position": 5,
            "url": "https://medtechterms.com/terms/intended-use",
            "name": "Intended Use",
            "description": "The single sentence that anchors your whole regulatory strategy."
          },
          {
            "@type": "ListItem",
            "position": 6,
            "url": "https://medtechterms.com/terms/indications-for-use",
            "name": "Indications for Use",
            "description": "The clinical situations your device is labeled for; drives evidence requirements."
          },
          {
            "@type": "ListItem",
            "position": 7,
            "url": "https://medtechterms.com/terms/predicate-device",
            "name": "Predicate Device",
            "description": "Why De Novo exists: what you file when no acceptable predicate is available."
          },
          {
            "@type": "ListItem",
            "position": 8,
            "url": "https://medtechterms.com/terms/substantial-equivalence",
            "name": "Substantial Equivalence",
            "description": "The 510(k) test you cannot meet, which is why you're reading this path."
          },
          {
            "@type": "ListItem",
            "position": 9,
            "url": "https://medtechterms.com/terms/510k",
            "name": "510(k) Premarket Notification",
            "description": "Compare to see why De Novo is different in evidence and outcome."
          },
          {
            "@type": "ListItem",
            "position": 10,
            "url": "https://medtechterms.com/terms/pma",
            "name": "Premarket Approval",
            "description": "Where you end up if FDA decides your device belongs in Class III instead."
          },
          {
            "@type": "ListItem",
            "position": 11,
            "url": "https://medtechterms.com/terms/combination-product",
            "name": "Combination Product",
            "description": "Extra Center-assignment step for device + drug or device + biologic products."
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Learning Paths",
            "item": "https://medtechterms.com/paths"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "De Novo & Breakthrough Pathways",
            "item": "https://medtechterms.com/paths/de-novo-and-breakthrough"
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

[All paths](/paths)RA · Startup · Product · 11 terms 

# De Novo & Breakthrough Pathways

Novel and expedited FDA pathways for devices with no predicate or that address unmet needs, plus Q-Submission and Pre-Submission mechanics.

Your progress

0 of 11 lessons complete · up next: De Novo Classification Request 

[Start path](/terms/de-novo?from=de-novo-and-breakthrough)

1.  1
    
    [
    
    Regulatory
    
    ## De Novo Classification Request(De Novo) 
    
    Pathway to classify novel low- to moderate-risk devices that lack a predicate.
    
    Why this term here: The pathway for novel low- to moderate-risk devices with no predicate.
    
    ](/terms/de-novo?from=de-novo-and-breakthrough)Mark done
    
2.  2
    
    [
    
    Regulatory
    
    ## Breakthrough Device Designation(BDD) 
    
    FDA program providing expedited review for devices that treat life-threatening or irreversibly debilitating conditions.
    
    Why this term here: Designation that unlocks expedited FDA interaction, not a separate submission type.
    
    ](/terms/breakthrough-device?from=de-novo-and-breakthrough)Mark done
    
3.  3
    
    [
    
    Commercialization
    
    ## Pre-Submission Meeting(Q-Sub) 
    
    Formal FDA feedback request prior to a marketing or IDE submission.
    
    Why this term here: The most valuable free tool FDA offers: written feedback before you file.
    
    ](/terms/pre-submission?from=de-novo-and-breakthrough)Mark done
    
4.  4
    
    [
    
    Regulatory
    
    ## Q-Submission (Pre-Submission)(Q-Sub / Pre-Sub) 
    
    Voluntary mechanism to obtain FDA feedback before a formal premarket submission.
    
    Why this term here: The umbrella program that contains Pre-Sub, Study Risk Determination, and more.
    
    ](/terms/q-sub?from=de-novo-and-breakthrough)Mark done
    
5.  5
    
    [
    
    Regulatory
    
    ## Intended Use
    
    The objective intent of the manufacturer regarding the use of the device.
    
    Why this term here: The single sentence that anchors your whole regulatory strategy.
    
    ](/terms/intended-use?from=de-novo-and-breakthrough)Mark done
    
6.  6
    
    [
    
    Regulatory
    
    ## Indications for Use(IFU (statement)) 
    
    Description of the disease or condition the device will diagnose, treat, prevent, cure, or mitigate.
    
    Why this term here: The clinical situations your device is labeled for; drives evidence requirements.
    
    ](/terms/indications-for-use?from=de-novo-and-breakthrough)Mark done
    
7.  7
    
    [
    
    Regulatory
    
    ## Predicate Device
    
    A legally marketed device used as the comparator in a 510(k) submission.
    
    Why this term here: Why De Novo exists: what you file when no acceptable predicate is available.
    
    ](/terms/predicate-device?from=de-novo-and-breakthrough)Mark done
    
8.  8
    
    [
    
    Regulatory
    
    ## Substantial Equivalence(SE) 
    
    The legal standard a 510(k) device must meet versus a predicate.
    
    Why this term here: The 510(k) test you cannot meet, which is why you're reading this path.
    
    ](/terms/substantial-equivalence?from=de-novo-and-breakthrough)Mark done
    
9.  9
    
    [
    
    Regulatory
    
    ## 510(k) Premarket Notification(510(k)) 
    
    FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
    
    Why this term here: Compare to see why De Novo is different in evidence and outcome.
    
    ](/terms/510k?from=de-novo-and-breakthrough)Mark done
    
10.  10
     
     [
     
     Regulatory
     
     ## Premarket Approval(PMA) 
     
     FDA's most stringent device marketing application, required for high-risk Class III devices.
     
     Why this term here: Where you end up if FDA decides your device belongs in Class III instead.
     
     ](/terms/pma?from=de-novo-and-breakthrough)Mark done
     
11.  11
     
     [
     
     Regulatory
     
     ## Combination Product
     
     Product comprised of two or more regulated components - e.g., drug-device, biologic-device.
     
     Why this term here: Extra Center-assignment step for device + drug or device + biologic products.
     
     ](/terms/combination-product?from=de-novo-and-breakthrough)Mark done
     

Finished the path? Test yourself with a quiz tailored to these 11 terms.

[Take the De Novo & Breakthrough Pathways quiz](/quiz?path=de-novo-and-breakthrough)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)